Pulse Biosciences, Inc Common Stock (DE) vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| PLSE | RMD | |
|---|---|---|
| Market Cap | $3.84 billion | $32.93 billion |
| Revenue (TTM) | $1.19 million | $5.65 billion |
| Net Income (TTM) | $-80,056,000 | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| PLSE | RMD | |
|---|---|---|
| P/E Ratio | — | 21.90 |
| Price / Book | 38.61 | 5.00 |
| Price / Sales | 3242.32 | 5.82 |
RMD leads on 2 of 2 valuation factors.
Profitability
| PLSE | RMD | |
|---|---|---|
| Net Margin | -6755.78% | 26.94% |
| Return on Equity | -80.46% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| PLSE | RMD | |
|---|---|---|
| Dividend Yield | — | 1.16% |
| Payout Ratio | — | 25.31 |
PLSE and RMD split the dividend factors evenly.
Risk & Sentiment
| PLSE | RMD | |
|---|---|---|
| Short Interest | 2.24% | 4.04% |
PLSE leads on 1 of 1 risk & sentiment factors.
Dig deeper: PLSE overview, PLSE financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.